These changes in AMPKα expression appeared to be AD specific, since AMPKα1/2 levels were unaffected in either Lewy body dementia or frontotemporal dementia (Zimmermann et al., 2020). The gene discussed is PRKAA1; the disease is Alzheimer disease.